Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [60Day-25-1357; Docket No. CDC-2024-0104]
 AGENCY: Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS).
 ACTION: Notice with comment period.
 SUMMARY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on a continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled The Greater Access and Impact with NAT (GAIN) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs). This study will identify facilitators and barriers with implementation of HIV point-of-care (POC) nucleic acid tests (NATs) in clinical settings, estimate the sensitivity and specificity of the HIV POC NAT, and assess the impact of the test in decreased time to receipt of HIV prevention and care.
 DATES: CDC must receive written comments on or before March 10, 2025.
 ADDRESSES: You may submit comments, identified by Docket No. CDC-2024-0104 by either of the following methods: *Federal eRulemaking Portal: www.regulations.gov.*
                         Follow the instructions for submitting comments.
                    *Mail:*
                         Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30329. *Instructions:*
                         All submissions received must include the agency name and Docket Number. CDC will post, without change, all relevant comments to 
                        *www.regulations.gov.* *Please note:*
                         Submit all comments through the Federal eRulemaking portal (
                        *www.regulations.gov*) or by U.S. mail to the address listed above.
 FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road, NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570; Email: 
                        *omb@cdc.gov.*


SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires federal agencies to provide a 60-day notice in the 
                    **Federal Register**
                     concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, 
                    *e.g.,*
                     permitting electronic submissions of responses; and 5. Assess information collection costs. Proposed Project The Greater Access and Impact with NAT (GAIN) Study: Improving HIV Diagnosis, Linkage to Care, and Prevention Services with HIV Point-of-Care Nucleic Acid Tests (NATs) (OMB Control No. 0920-1357, Exp. 12/31/2024)—Reinstatement—National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC) Background and Brief Description HIV prevention and care services can be improved by the availability of Point-of-care (POC) HIV viral RNA testing in clinical settings. Viral RNA tests are the most sensitive HIV tests for the detection of early infection. The purpose of this data collection is to develop feasible and effective models to integrate HIV POC nucleic acid tests (NATs) in HIV prevention and treatment services. The HIV POC NAT can be used to test persons at high-risk of acquiring HIV infection to reduce the time 
                    ( print page 1502)
                    between testing in community-based and clinical-based settings and linkage to HIV care, ART initiation, and viral suppression. Data will be used to compare an HIV RNA POC NAT to standard lab-based HIV testing. The data will be analyzed and disseminated to describe the real-world performance and clinical usefulness of HIV RNA POC NAT technology. Data will be gathered through: clinical site extraction of electronic medical records for use as a retrospective baseline comparator after study implementation; a longitudinal, prospective study of persons without HIV seeking HIV testing or PrEP services; a longitudinal, prospective study of persons with HIV seeking STI testing; a randomized clinical trial of HIV POC NAT or standard of care for persons with HIV; a survey, interviews, and focus groups to understand HIV POC NAT acceptability among persons without HIV and persons with HIV; an assessment of the performance of an HIV POC NAT among persons with HIV; and an acceptability/feasibility assessment among clinical and community providers and costing analyses. CDC is requesting OMB approval for estimated 880 annual burden hours. There are no costs to respondents other than their time. Estimated Annualized Burden Hours
Type of respondent
Form name
Number of respondents
Number of 
                             responses  
                             per respondent
Average
                             burden per  
                             response 
                             (in hours)
Total burden
                             (in hours)Participating Clinic
Baseline data collection variables list
2
1
2
4Monthly study report form
2
12
15/60
6Participants in prospective study of persons without HIV seeking HIV testing and/or PrEP services
Release of information form
850
1
10/60
142Study visit survey
850
1
15/60
213Participants in prospective study of persons with HIV seeking STI testing
Release of information form
50
1
10/60
8Study visit survey
50
1
15/60
13Participants in RCT of POC NAT or Standard of Care for persons with HIV
Release of information form
212
1
10/60
35Study visit survey
212
1
15/60
53Participants in survey group examining POC NAT acceptability
POC NAT acceptability survey
500
1
20/60
167Participants in cross-sectional comparison of several point-of-care NATs
Release of information form
333
1
10/60
56Study visit survey
333
1
15/60
83Participants in the acceptability/feasibility assessment
POC NAT acceptability survey, focus group, or interview
100
1
1
100Total




880
 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Public Health Ethics and Regulations, Office of Science, Centers for Disease Control and Prevention.


[FR Doc. 2025-00166 Filed 1-7-25; 8:45 am] BILLING CODE 4163-18-P